Kerr Douglas — SEC insider filings

SEC reporting owner CIK 1814189. 31 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 31 filings on record, filed 2021-01-13 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Generation Bio Co. (GBIO)CHIEF MEDICAL OFFICER16—16 legs · 51,391 sh · $1,553,11142
Dyne Therapeutics, Inc. (DYN)Head of R&D and CMO15—12 legs · 20,540 sh · $369,5599

Insider filings — Kerr Douglas

FiledFormIssuerReported transactionsSource
2026-11-164Dyne Therapeutics, Inc. (DYN)Sale (S): 2,604 @ $16.82EDGAR
2026-10-224Dyne Therapeutics, Inc. (DYN)Grant/award (A): 8,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2026-09-084Dyne Therapeutics, Inc. (DYN)Sale (S): 3,745 @ $24.35 · Sale (S): 1,290 @ $18.88EDGAR
2026-08-174Dyne Therapeutics, Inc. (DYN)Sale (S): 1,556 @ $26.28EDGAR
2026-06-174Dyne Therapeutics, Inc. (DYN)Sale (S): 887 @ $18.33EDGAR
2026-05-144Dyne Therapeutics, Inc. (DYN)Sale (S): 1,564 @ $18.36EDGAR
2026-03-064Dyne Therapeutics, Inc. (DYN)Sale (S): 904 @ $14.90EDGAR
2026-02-174Dyne Therapeutics, Inc. (DYN)Grant/award (A): 85,000 @ $0 · Grant/award (A): 130,000 (derivative) @ $0EDGAR
2025-12-054Dyne Therapeutics, Inc. (DYN)Sale (S): 880 @ $20.72EDGAR
2025-09-084Dyne Therapeutics, Inc. (DYN)Sale (S): 3,552 @ $13.27 · Sale (S): 873 @ $13.41EDGAR
2025-07-184Dyne Therapeutics, Inc. (DYN)Grant/award (A): 65,110 (derivative) @ $0EDGAR
2025-06-064Dyne Therapeutics, Inc. (DYN)Sale (S): 1,342 @ $13.35EDGAR
2025-03-074Dyne Therapeutics, Inc. (DYN)Sale (S): 1,343 @ $11.83EDGAR
2024-12-064Dyne Therapeutics, Inc. (DYN)Grant/award (A): 48,000 @ $0 · Grant/award (A): 76,600 (derivative) @ $0EDGAR
2024-09-034Dyne Therapeutics, Inc. (DYN)Grant/award (A): 47,500 @ $0 · Grant/award (A): 150,300 (derivative) @ $0EDGAR
2024-01-314Generation Bio Co. (GBIO)Option exercise (M): 5,021 · Tax withholding (F): 1,476 @ $1.90 · Option exercise (M): 5,021 (derivative) @ $0EDGAR
2024-01-174Generation Bio Co. (GBIO)Option exercise (M): 7,437 · Tax withholding (F): 2,577 @ $1.91 · Option exercise (M): 6,694 · Tax withholding (F): 2,320 @ $1.91 · Option exercise (M): 7,437 (derivative) @ $0 · Option exercise (M): 6,694 (derivative) @ $0EDGAR
2023-10-174Generation Bio Co. (GBIO)Option exercise (M): 7,437 · Tax withholding (F): 2,183 @ $3.24 · Option exercise (M): 7,437 (derivative) @ $0EDGAR
2023-07-184Generation Bio Co. (GBIO)Option exercise (M): 7,437 · Tax withholding (F): 2,183 @ $5.08 · Option exercise (M): 7,437 (derivative) @ $0EDGAR
2023-04-184Generation Bio Co. (GBIO)Option exercise (M): 7,437 · Tax withholding (F): 2,183 @ $4.50 · Option exercise (M): 7,437 (derivative) @ $0EDGAR
2023-01-244Generation Bio Co. (GBIO)Grant/award (A): 53,550 (derivative) @ $0 · Grant/award (A): 26,775 (derivative) @ $0EDGAR
2023-01-184Generation Bio Co. (GBIO)Option exercise (M): 7,438 · Tax withholding (F): 2,578 @ $5.10 · Option exercise (M): 7,438 (derivative) @ $0EDGAR
2022-10-184Generation Bio Co. (GBIO)Option exercise (M): 7,438 · Tax withholding (F): 2,184 @ $5.61 · Option exercise (M): 7,438 (derivative) @ $0EDGAR
2022-07-194Generation Bio Co. (GBIO)Option exercise (M): 14,876 · Tax withholding (F): 4,367 @ $7.18 · Option exercise (M): 14,876 (derivative) @ $0EDGAR
2022-01-254Generation Bio Co. (GBIO)Grant/award (A): 119,000 (derivative) @ $0 · Grant/award (A): 59,500 (derivative) @ $0EDGAR
2021-07-124Generation Bio Co. (GBIO)Option exercise (M): 3,518 @ $5.16 · Sale (S): 1,629 @ $24.99 · Sale (S): 1,889 @ $25.39 · Option exercise (M): 3,518 (derivative) @ $0EDGAR
2021-04-074Generation Bio Co. (GBIO)Option exercise (M): 14,072 @ $5.16 · Sale (S): 10,751 @ $29.91 · Sale (S): 3,321 @ $30.68 · Option exercise (M): 14,072 (derivative) @ $0EDGAR
2021-03-094Generation Bio Co. (GBIO)Option exercise (M): 11,267 @ $4.59 · Sale (S): 2,677 @ $29.68 · Sale (S): 2,500 @ $30.92 · Sale (S): 4,315 @ $31.87 · Sale (S): 775 @ $32.97 · Sale (S): 400 @ $33.75 · +3 moreEDGAR
2021-02-104Generation Bio Co. (GBIO)Option exercise (M): 11,267 @ $4.59 · Sale (S): 7,500 @ $33.01 · Sale (S): 3,767 @ $34.08 · Option exercise (M): 11,267 (derivative) @ $0EDGAR
2021-02-054Generation Bio Co. (GBIO)Grant/award (A): 73,500 (derivative) @ $0EDGAR
2021-01-134Generation Bio Co. (GBIO)Option exercise (M): 11,267 @ $4.59 · Sale (S): 6,246 @ $27.17 · Sale (S): 4,721 @ $28.05 · Sale (S): 300 @ $28.80 · Option exercise (M): 11,267 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1814189 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs